Resistance to antiangiogenic therapy involves metabolic symbiosis patterning in RCC
•
mTOR pathway mediates this resistance and mTOR inhibition blocks metabolic symbiosis
•
In patients, antiangiogenics induce symbiotic patterning mostly in resistant tumors
•
mTOR pathway implication is also suggested in patients treated with antiangiogenics
NGLC 2004-2010.National Geological Library of China All Rights Reserved.
Add:29 Xueyuan Rd,Haidian District,Beijing,PRC. Mail Add: 8324 mailbox 100083
For exchange or info please contact us via email.